Involved-field radiotherapy with concurrent chemotherapy for limited-stage small-cell lung cancer: Disease control, patterns of failure and survival

Journal of Medical Imaging and Radiation Oncology

Volumn 54, Issue 5, 2010, Pages 483-489

  Watkins, John M ^a   Wahlquist, Amy E ^a   Zauls, A Jason ^a   Shirai, Keisuke ^a   Garrett Mayer, Elizabeth ^a   Aguero, Eric G ^a   Silvestri, Gerard A ^a   Sherman, Carol A ^a   Sharma, Anand K ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

combined modality therapy; hyperfractionation; lung neoplasms; radiotherapy; small cell carcinoma

Indexed keywords

CARBOPLATIN; CISPLATIN; ETOPOSIDE;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE; TREATMENT FAILURE;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, SMALL CELL; CISPLATIN; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; ETOPOSIDE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 78349290434     PISSN: 17549477     EISSN: 17549485     Source Type: Journal    
DOI: 10.1111/j.1754-9485.2010.02201.x     Document Type: Article

References (21)

1. Pignon JP, Arriagada R, Ihde DC, etal. A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med 1992; 327: 1618 - 24.
2. Warde P, Payne D,. Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis. J Clin Oncol 1992; 10: 890 - 5.
3. Turrisi AT, Kim K, Blum R, etal. Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med 1999; 340: 265 - 71.
4. Takada M, Fukuoka M, Kawahara M, etal. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group study 9104. J Clin Oncol 2002; 20: 3054 - 60.
5. Spiro SG, James LE, Rudd RM, etal. Early compared with late radiotherapy in combined modality treatment for limited disease small-cell lung cancer: a London Lung Cancer Group multicenter randomized clinical trial and meta-analysis. J Clin Oncol 2006; 24: 3823 - 30.
6. Bonner JA, Sloan JA, Shanahan TG, etal. Phase III comparison of twice-daily split-course irradiation versus once-daily irradiation for patients with limited stage small-cell lung carcinoma. J Clin Oncol 1999; 17: 2681 - 91.
7. De Ruysscher D, Bremer R-H, Koppe F, etal. Omission of elective node irradiation on basis of CT-scans in patients with limited disease small cell lung cancer: a phase II trial. Radiother Oncol 2006; 80: 307 - 12.
8. 18FDG-PET scans in limited-stage small-cell lung cancer: a prospective study. Int J Radiat Oncol Biol Phys 2010; 77: 329 - 36.
9. Baas P, Belderbos JSA, Senan S, etal. Concurrent chemotherapy (carboplatin, paclitaxel, etoposide) and involved-field radiotherapy in limited-stage small cell lung cancer: a Dutch multicenter phase II study. Br J Cancer 2006; 94: 625 - 30.
10. Belderbos J, Baas P, Senan S,. Reply: patterns of nodal recurrence after omission of elective nodal irradiation for limited-stage small-cell lung cancer. Br J Cancer 2007; 97: 276.
11. Videtic GMM, Belderbos JSA, Kong FM, Kepka L, Martel MK, Jeremic B,. Report from the International Atomic Energy Agency (IAEA) consultants' meeting on elective nodal irradiation in lung cancer: small-cell lung cancer (SCLC). Int J Radiat Oncol Biol Phys 2008; 72: 327 - 34.
12. Gomez de Antonio D, Alfageme F, Gamez P, Cordoba M, Varela A,. Results of surgery in small cell carcinoma of the lung. Lung Cancer 2006; 52: 299 - 304.
13. Bradley JD, Dehdashti F, Mintun MA, Govindan R, Trinkaus K, Siegel BA,. Positron emission tomography in limited-stage small-cell lung cancer: a prospective study. J Clin Oncol 2004; 22: 3248 - 54.
14. 18F]FDG-PET on the primary staging of small-cell lung cancer. Eur J Nucl Med Mol Imaging 2004; 31: 1614 - 20.
15. 18FDG-PET based radiation planning of mediastinal lymph nodes in limited disease small cell lung cancer changes radiotherapy fields: a planning study. Radiother Oncol 2008; 87: 49 - 54.
16. Van Overhangen H, Brakel K, Heijenbrok MW, Van Kasteren JH, etal. Metastases in supraclavicular lymph nodes in lung cancer: assessment with palpation, US, and CT. Radiology 2004; 232: 75 - 80.
17. Movsas B, Moughan J, Komaki R, etal. Radiotherapy patterns of care study in lung carcinoma. J Clin Oncol 2003; 21: 4553 - 9.
18. Uno T, Sumi M, Ishihara Y, etal. Changes in patterns of care for limited-stage small-cell lung cancer: results of the 99-01 patterns of care study - a nationwide survey in Japan. Int J Radiat Oncol Biol Phys 2008; 27: 414 - 9.
19. Komaki R, Swann RS, Ettinger DS, etal. Phase I study of thoracic radiation dose escalation with concurrent chemotherapy for patients with limited small-cell lung cancer: report of Radiation Therapy Oncology Group (RTOG) protocol 97-12. Int J Radiat Oncol Biol Phys 2005; 62: 342 - 50.
20. Choi NC, Herndon JE, Rosenman J, etal. Phase I study to determine the maximum-tolerated dose of radiation in standard daily and hyperfractionated- accelerated twice-daily radiation schedules with concurrent chemotherapy for limited-stage small-cell lung cancer. J Clin Oncol 1998; 16: 3528 - 36.
21. Watkins JM, Wahlquist AE, Shirai K, etal. Factors associated with severe acute esophagitis from hyperfractionated radiotherapy with concurrent chemotherapy for limited-stage small-cell lung cancer. Int J Radiat Oncol Biol Phys 2009; 74: 1108 - 13.